Survival of motor neuron

May 11, 2020

Save Nil's Life: Crowdfunding Campaign Created in Fight Against Spinal Muscular Atrophy (SMA) Type 2

Nov 11, 2019

Risdiplam (RG7916) Pivotal SUNFISH Study Demonstrates Statistically Significant Improvement for Patients with Type 2/3 Spinal Muscular Atrophy

May 24, 2019

MDA Celebrates FDA Approval of Zolgensma for Treatment of Spinal Muscular Atrophy in Pediatric Patients

Oct 03, 2018

Risdiplam Demonstrates Preliminary Evidence of Clinical Benefit in Type 1, 2, & 3 Spinal Muscular Atrophy Patients

Jun 16, 2018

Updated Preliminary Data from SMA FIREFISH Program in Type 1 Babies Presented at the CureSMA Conference

Apr 27, 2018

Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA)

Apr 18, 2018

Preliminary Study Suggests Drug May Help Babies with Spinal Muscular Atrophy

Jan 27, 2018

Preliminary Data from FIREFISH trial in Type 1 SMA Infants Presented at the International Scientific Congress on Spinal Muscular Atrophy

Oct 27, 2017

Ionis and Biogen Win Prestigious Prix Galien Best Biotechnology Product Award for SPINRAZA

Oct 12, 2017

Spinal Muscular Atrophy Program Advances into Pivotal Study in SMA Patients

Aug 30, 2017

Ionis Earns $40 Million SPINRAZA Regulatory Milestone Payment from Biogen

Jun 01, 2017

SPINRAZA® (nusinersen) Approved in the European Union